Pembrolizumab Injectable

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 2
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2024-12-06T01:13:08-05:00",
  "meta" : {
    "versionId" : "11",
    "lastUpdated" : "2024-12-06T01:13:08.000-05:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "American Society of Clinical Oncology Steward",
  "jurisdiction" : [ {
    "coding" : [ {
      "system" : "urn:iso:std:iso:3166",
      "code" : "US"
    } ]
  } ],
  "purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts of medication Pembrolizumab.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication Pembrolizumab; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)",
  "name" : "PembrolizumabInjectable",
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1657746",
      "display" : "pembrolizumab 50 MG Injection",
      "version" : "11042024"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1657750",
      "display" : "4 ML pembrolizumab 25 MG/ML Injection",
      "version" : "11042024"
    } ],
    "total" : 2,
    "identifier" : "urn:uuid:0798506f-e816-4b91-87d8-ae716d0ea682",
    "timestamp" : "2024-12-10T10:10:38-05:00"
  },
  "title" : "Pembrolizumab Injectable",
  "extension" : [ {
    "valueContactDetail" : {
      "name" : "American Society of Clinical Oncology Author"
    },
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2024-12-06",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2024-12-06",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "149e4679-70a9-4109-bf7b-50dd83fd3964",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.3.189",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113883.3.1444.3.189"
  } ],
  "version" : "20241206"
}